172@29@17@241!~!172@29@0@53!~!|news|business|moneycontrol-research|aurobindo-pharma-shot-in-the-arm-for-covid-vaccine-development-programme-5845801.html!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
App
Moneycontrol AppAndroid AppiOS AppiPad AppAndroid TabBlackberryWindows AppWindows Tab
Subscription
Specials
Stocks
Feedback
Log In
Sign Up
Moneycontrol
Here is your gateway to a 1-year FREE MC Pro Subscription, by applying for an American Express card. Apply Now!
you are here: HomeNewsBusinessMoneycontrol Research
  
  1
Last Updated Last Updated : Sep 16, 2020 10:26 AM IST | Source: Moneycontrol.com

Aurobindo Pharma: Shot in the arm for Covid vaccine development programme

Vaccine capacity creation puts Aurobindo in the league of Serum Institute of India and Cadila in the race for a Covid drug

Anubhav Sahu

To view the full content of this article, you have to be a Pro:

  • Not a Moneycontrol Pro subscriber yet?

Subscribe to Moneycontrol Pro:

What's included:

  • Ad free experience across Platforms
  • 230+ exclusive stories per month
  • Sharpest Opinions & Actionable Insights
  • Exclusive Research & Expert Technical Analysis
  • Daily Newsletter
  • 20+ Technical Picks every week
  • Recovery Tracker
  • Exclusive webinars on varied topics
  • Weekly wrap up and much more!!!
Subscribe to Annual plan of PRO at Rs. 365/- for the first year and unlock offers worth Rs. 15,000/- »